Opiant Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Opiant Pharmaceuticals Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Opiant Pharmaceuticals, the average price target is $0.00, with a high estimate of $0.00 and a low estimate of $0.00. That is a potential downside of approximately 0 from the last closing price of $20.77 on February, 2023. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
N/A
Opiant Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
In the last year, Opiant Pharmaceuticals's Revenue has grown by 61.29%, from $29.63M to $47.79M. In the following year, 0 experts forecast Opiant Pharmaceuticals's Revenue will decrease by 38.00%, to $29.63M. In 2030, professionals predict that Opiant Pharmaceuticals's Revenue will decrease by 17.53%, to $39.41M.
.jpg)
Opiant Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Opiant Pharmaceuticals's EBITDA has grown by 347.64%, rising from $-2.12M to $5.25M. According to 0 analysts, Opiant Pharmaceuticals's EBITDA will fall by 140.38% in the next year, reaching $-2.12M. Professionals believe that By 2030, Opiant Pharmaceuticals's EBITDA will fall to $-11.17M – a 312.72% decrease from its current value.
Opiant Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last year, Opiant Pharmaceuticals's EBIT has grown, rising from $-2.24M to $5.16M – a growth of 330.36%. In the following year, 0 experts forecast that Opiant Pharmaceuticals's EBIT will decrease by 143.41%, to $-2.24M. In 2030, professionals predict that Opiant Pharmaceuticals's EBIT will decrease by 307.22%, to $-10.69M.
Site Navigation
.jpg)